Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas. Staudacher JJ, Arnold A, Kuhl AA, Potzsch M, et al. BMC Cancer 2022;22:953.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Staudacher JJ, Arnold A, Kuhl AA, Potzsch M, et al. Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas. BMC Cancer 2022;22:953.
PMID: 36064338